Literature DB >> 28329242

Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia.

Hatice Karauzum1, Christian C Haudenschild1, Ian N Moore2, Mahta Mahmoudieh1, Daniel L Barber3, Sandip K Datta1.   

Abstract

Multiple candidate vaccines against Staphylococcus aureus infections have failed in clinical trials. Analysis of a recent prematurely halted vaccine trial revealed increased mortality rates among vaccine recipients in whom postsurgical S. aureus infection developed, emphasizing the potential for induction of detrimental immune responses and the need to better understand the requirements for protective immunity against S. aureus. These failures of single-antigen vaccines have prompted ongoing development of multicomponent vaccines to target the multitude of S. aureus virulence factors. In the current study, we used lethally irradiated S. aureus as a model multicomponent vaccine and showed that vaccination of mice decreased survival in a bacteremia challenge model. These deleterious effects were due to a CD4 T-cell-dependent interferon γ response and could be prevented by inhibiting development of this response during vaccination. Our results identify the potential for vaccination to induce pathological immune responses, and they have implications for recent vaccine failures and the design of future staphylococcal vaccines. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  IFN-γ;; Staphylococcus aureus; Th1 cells; immunopathology.; systemic infection; vaccination

Mesh:

Substances:

Year:  2017        PMID: 28329242      PMCID: PMC5853805          DOI: 10.1093/infdis/jix096

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

Authors:  Vance G Fowler; Keith B Allen; Edson D Moreira; Moustafa Moustafa; Frank Isgro; Helen W Boucher; G Ralph Corey; Yehuda Carmeli; Robert Betts; Jonathan S Hartzel; Ivan S F Chan; Tessie B McNeely; Nicholas A Kartsonis; Dalya Guris; Matthew T Onorato; Steven S Smugar; Mark J DiNubile; Ajoke Sobanjo-ter Meulen
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

2.  Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection.

Authors:  Pablo Penaloza-MacMaster; Daniel L Barber; E John Wherry; Nicholas M Provine; Jeffrey E Teigler; Lily Parenteau; Stephen Blackmore; Erica N Borducchi; Rafael A Larocca; Kathleen B Yates; Hao Shen; W Nicholas Haining; Rami Sommerstein; Daniel D Pinschewer; Rafi Ahmed; Dan H Barouch
Journal:  Science       Date:  2015-01-16       Impact factor: 47.728

Review 3.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors.

Authors:  Tessie B McNeely; Najaf A Shah; Arthur Fridman; Amita Joshi; Jonathan S Hartzel; Ravi S Keshari; Florea Lupu; Mark J DiNubile
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 5.  Waves of resistance: Staphylococcus aureus in the antibiotic era.

Authors:  Henry F Chambers; Frank R Deleo
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

Review 6.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

Review 7.  Detection and clinical relevance of Staphylococcus aureus nasal carriage: an update.

Authors:  Paul O Verhoeven; Julie Gagnaire; Elisabeth Botelho-Nevers; Florence Grattard; Anne Carricajo; Frédéric Lucht; Bruno Pozzetto; Philippe Berthelot
Journal:  Expert Rev Anti Infect Ther       Date:  2013-11-26       Impact factor: 5.091

8.  Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model.

Authors:  Amita Joshi; Greg Pancari; Leslie Cope; Edward P Bowman; Daniel Cua; Richard A Proctor; Tessie McNeely
Journal:  Hum Vaccin Immunother       Date:  2012-02-13       Impact factor: 3.452

9.  Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.

Authors:  A Fattom; R Schneerson; S C Szu; W F Vann; J Shiloach; W W Karakawa; J B Robbins
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.609

10.  Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.

Authors:  Clarissa Pozzi; Katarzyna Wilk; Jean C Lee; Marina Gening; Nikolay Nifantiev; Gerald B Pier
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more
  12 in total

1.  Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection.

Authors:  Carly A Dillen; Bret L Pinsker; Alina I Marusina; Alexander A Merleev; Orly N Farber; Haiyun Liu; Nathan K Archer; Da B Lee; Yu Wang; Roger V Ortines; Steven K Lee; Mark C Marchitto; Shuting S Cai; Alyssa G Ashbaugh; Larissa S May; Steven M Holland; Alexandra F Freeman; Loren G Miller; Michael R Yeaman; Scott I Simon; Joshua D Milner; Emanual Maverakis; Lloyd S Miller
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

2.  Antigenic landscapes on Staphylococcus aureus pore-forming toxins reveal insights into specificity and cross-neutralization.

Authors:  Shweta Kailasan; Ravi Kant; Madeleine Noonan-Shueh; Tulasikumari Kanipakala; Grant Liao; Sergey Shulenin; Daisy W Leung; Richard A Alm; Rajan P Adhikari; Gaya K Amarasinghe; Michael L Gross; M Javad Aman
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

3.  Vaccine display on artificial bacterial spores enhances protective efficacy against Staphylococcus aureus infection.

Authors:  Hatice Karauzum; Taylor B Updegrove; Minsuk Kong; I-Lin Wu; Sandip K Datta; Kumaran S Ramamurthi
Journal:  FEMS Microbiol Lett       Date:  2018-09-01       Impact factor: 2.742

4.  Two Vaccines for Staphylococcus aureus Induce a B-Cell-Mediated Immune Response.

Authors:  Christopher D Dupont; Ingrid L Scully; Ross M Zimnisky; Brinda Monian; Christina P Rossitto; Ellen B O'Connell; Kathrin U Jansen; Annaliesa S Anderson; J Christopher Love
Journal:  mSphere       Date:  2018-08-22       Impact factor: 4.389

5.  A Critical Role for HlgA in Staphylococcus aureus Pathogenesis Revealed by A Switch in the SaeRS Two-Component Regulatory System.

Authors:  Arundhathi Venkatasubramaniam; Tulasikumari Kanipakala; Nader Ganjbaksh; Rana Mehr; Ipsita Mukherjee; Subramaniam Krishnan; Taeok Bae; M Javad Aman; Rajan P Adhikari
Journal:  Toxins (Basel)       Date:  2018-09-18       Impact factor: 4.546

6.  Memory CD4 T cell-derived IL-2 synergizes with viral infection to exacerbate lung inflammation.

Authors:  K Kai McKinstry; Fahmida Alam; Valeria Flores-Malavet; Mate Z Nagy; Stewart Sell; Andrea M Cooper; Susan L Swain; Tara M Strutt
Journal:  PLoS Pathog       Date:  2019-08-14       Impact factor: 6.823

Review 7.  Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.

Authors:  Lloyd S Miller; Vance G Fowler; Sanjay K Shukla; Warren E Rose; Richard A Proctor
Journal:  FEMS Microbiol Rev       Date:  2020-01-01       Impact factor: 16.408

8.  IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus.

Authors:  Hatice Karauzum; Arundhathi Venkatasubramaniam; Rajan P Adhikari; Tom Kort; Frederick W Holtsberg; Ipsita Mukherjee; Mark Mednikov; Roger Ortines; Nhu T Q Nguyen; Thien M N Doan; Binh An Diep; Jean C Lee; M Javad Aman
Journal:  Front Immunol       Date:  2021-03-10       Impact factor: 7.561

9.  Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques.

Authors:  Arundhathi Venkatasubramaniam; Grant Liao; Eunice Cho; Rajan P Adhikari; Tom Kort; Frederick W Holtsberg; Karen E Elsass; Dean J Kobs; Thomas L Rudge; Keith D Kauffman; Nickiana E Lora; Daniel L Barber; M Javad Aman; Hatice Karauzum
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

10.  Impaired T-Lymphocyte Responses During Childhood Staphylococcus aureus Infection.

Authors:  Zhaotao Li; Pavani Beesetty; George Gerges; Maureen Kleinhenz; Melissa Moore-Clingenpeel; Ching Yang; Luul B Ahmed; Josey Hensley; Lisa Steele; Anita S Chong; Christopher P Montgomery
Journal:  J Infect Dis       Date:  2022-01-05       Impact factor: 7.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.